Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Kymera Therapeutics (KYMR) Shares Issued: 2020-2025

Historic Shares Issued for Kymera Therapeutics (KYMR) over the last 4 years, with Sep 2025 value amounting to -$711,000.

  • Kymera Therapeutics' Shares Issued was N/A to -$711,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $62.1 million, marking a year-over-year change of. This contributed to the annual value of $48.7 million for FY2024, which is 1604.20% up from last year.
  • As of Q3 2025, Kymera Therapeutics' Shares Issued stood at -$711,000, which was down 105.27% from $13.5 million recorded in Q2 2025.
  • Kymera Therapeutics' 5-year Shares Issued high stood at $48.7 million for Q1 2024, and its period low was -$711,000 during Q3 2025.
  • Over the past 3 years, Kymera Therapeutics' median Shares Issued value was $620,000 (recorded in 2023), while the average stood at $8.1 million.
  • Its Shares Issued has fluctuated over the past 5 years, first skyrocketed by 3,179.95% in 2024, then plummeted by 98.90% in 2025.
  • Kymera Therapeutics' Shares Issued (Quarterly) stood at $1.8 million in 2021, then decreased by 22.41% to $1.4 million in 2022, then plummeted by 58.72% to $563,000 in 2023, then surged by 3,179.95% to $48.7 million in 2024, then crashed by 98.90% to -$711,000 in 2025.
  • Its last three reported values are -$711,000 in Q3 2025, $13.5 million for Q2 2025, and $535,000 during Q1 2025.